Endothelial cells cultured from human umbilical vein release ATP, substance P and acetylcholine in response to increased flow.

Hypoxia is an effective stimulus for vesicular release of ATP from human umbilical vein endothelial cells.

Rapid release of endothelin and ATP from isolated aortic endothelial cells exposed to increased flow.

Increased flow-induced ATP release from isolated vascular endothelial cells but not smooth muscle cells.

Increased expression of thrombomodulin on the cultured human umbilical vein endothelial cells and mouse hemangioma cells by cyclic AMP.

Hypoxia increases stimulus-induced PAF production and release from human umbilical vein endothelial cells.

The binding of plasminogen fragments to cultured human umbilical vein endothelial cells.

KNDC1 knockdown protects human umbilical vein endothelial cells from senescence.

Effect of extracellular ATP level on flow-induced Ca++ response in cultured vascular endothelial cells.

The effects of cetirizine on the adhesion of human eosinophils and neutrophils to cultured human umbilical vein endothelial cells.

Cyclic AMP increases thrombomodulin expression on membrane surface of cultured human umbilical vein endothelial cells.

Agonist-stimulated divalent cation entry into single cultured human umbilical vein endothelial cells.

Retinoic acid receptor transcripts in human umbilical vein endothelial cells.

SIRT4 Suppresses Inflammatory Responses in Human Umbilical Vein Endothelial Cells.

Vascular cell adhesion molecule-1 and eosinophil adhesion to cultured human umbilical vein endothelial cells in vitro.

Vitamin D suppresses oxidative stress-induced microparticle release by human umbilical vein endothelial cells.

Characterization of extracellular signal-regulated kinase 5 levels in human umbilical vein endothelial cells exposed to disturbed and uniform flow.

HSPA12B inhibits lipopolysaccharide-induced inflammatory response in human umbilical vein endothelial cells.

Regulation of eicosanoid release in human umbilical endothelial cells.

Chronic cardiovascular disease-associated gene network analysis in human umbilical vein endothelial cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Morphological analysis of human umbilical vein endothelial cells co-cultured with ovarian cancer cells in 3D: An oncogenic angiogenesis assay.

Propofol protects against high glucose-induced endothelial apoptosis and dysfunction in human umbilical vein endothelial cells.

Comprehensive and computational analysis of genes in human umbilical vein endothelial cells responsive to X-irradiation.

Control of proliferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor, and thrombin.

Insulin reverses D-glucose-increased nitric oxide and reactive oxygen species generation in human umbilical vein endothelial cells.

Suggest Documents

Hypoxia is an effective stimulus for vesicular release of ATP from human umbilical vein endothelial cells.

Rapid release of endothelin and ATP from isolated aortic endothelial cells exposed to increased flow.

Increased flow-induced ATP release from isolated vascular endothelial cells but not smooth muscle cells.

Increased expression of thrombomodulin on the cultured human umbilical vein endothelial cells and mouse hemangioma cells by cyclic AMP.

Hypoxia increases stimulus-induced PAF production and release from human umbilical vein endothelial cells.

The binding of plasminogen fragments to cultured human umbilical vein endothelial cells.

KNDC1 knockdown protects human umbilical vein endothelial cells from senescence.

Effect of extracellular ATP level on flow-induced Ca++ response in cultured vascular endothelial cells.

The effects of cetirizine on the adhesion of human eosinophils and neutrophils to cultured human umbilical vein endothelial cells.

Cyclic AMP increases thrombomodulin expression on membrane surface of cultured human umbilical vein endothelial cells.

Agonist-stimulated divalent cation entry into single cultured human umbilical vein endothelial cells.

Retinoic acid receptor transcripts in human umbilical vein endothelial cells.

SIRT4 Suppresses Inflammatory Responses in Human Umbilical Vein Endothelial Cells.

Vascular cell adhesion molecule-1 and eosinophil adhesion to cultured human umbilical vein endothelial cells in vitro.

Vitamin D suppresses oxidative stress-induced microparticle release by human umbilical vein endothelial cells.

Characterization of extracellular signal-regulated kinase 5 levels in human umbilical vein endothelial cells exposed to disturbed and uniform flow.

HSPA12B inhibits lipopolysaccharide-induced inflammatory response in human umbilical vein endothelial cells.

Regulation of eicosanoid release in human umbilical endothelial cells.

Chronic cardiovascular disease-associated gene network analysis in human umbilical vein endothelial cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Morphological analysis of human umbilical vein endothelial cells co-cultured with ovarian cancer cells in 3D: An oncogenic angiogenesis assay.

Propofol protects against high glucose-induced endothelial apoptosis and dysfunction in human umbilical vein endothelial cells.

Comprehensive and computational analysis of genes in human umbilical vein endothelial cells responsive to X-irradiation.

Control of proliferation of human vascular endothelial cells. Characterization of the response of human umbilical vein endothelial cells to fibroblast growth factor, epidermal growth factor, and thrombin.

Insulin reverses D-glucose-increased nitric oxide and reactive oxygen species generation in human umbilical vein endothelial cells.

Endothelial cells cultured from human umbilical vein release ATP, substance P and acetylcholine in response to increased flow.

Recommend Documents

Follow Us